Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas

Blood Adv. 2024 Feb 13;8(3):780-784. doi: 10.1182/bloodadvances.2023011997.

¹ Division of Oncology, Department of Medicine, Stanford University, Stanford, CA.
² Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA.
³ Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.
⁴ Department of Radiation Oncology, Stanford University, Stanford, CA.
⁵ Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
⁶ Stanford Cancer Institute, Stanford University, Stanford, CA.
⁷ Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA.

No abstract available

MeSH terms